303 related articles for article (PubMed ID: 27807222)
21. Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs.
Lorenzen JM; Batkai S; Thum T
Free Radic Biol Med; 2013 Sep; 64():78-84. PubMed ID: 23845966
[TBL] [Abstract][Full Text] [Related]
22. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
Yoshioka J; Schulze PC; Cupesi M; Sylvan JD; MacGillivray C; Gannon J; Huang H; Lee RT
Circulation; 2004 Jun; 109(21):2581-6. PubMed ID: 15123525
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.
Tsubaki H; Tooyama I; Walker DG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302545
[TBL] [Abstract][Full Text] [Related]
24. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer.
Zhou J; Chng WJ
Mitochondrion; 2013 May; 13(3):163-9. PubMed ID: 22750447
[TBL] [Abstract][Full Text] [Related]
25. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
[TBL] [Abstract][Full Text] [Related]
26. PICOT alleviates myocardial ischemia-reperfusion injury by reducing intracellular levels of reactive oxygen species.
Kim J; Kim J; Kook H; Park WJ
Biochem Biophys Res Commun; 2017 Apr; 485(4):807-813. PubMed ID: 28257842
[TBL] [Abstract][Full Text] [Related]
27. Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook.
Qayyum N; Haseeb M; Kim MS; Choi S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803178
[TBL] [Abstract][Full Text] [Related]
28. Melatonin rescues cardiac thioredoxin system during ischemia-reperfusion injury in acute hyperglycemic state by restoring Notch1/Hes1/Akt signaling in a membrane receptor-dependent manner.
Yu L; Fan C; Li Z; Zhang J; Xue X; Xu Y; Zhao G; Yang Y; Wang H
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27753144
[TBL] [Abstract][Full Text] [Related]
29. Thioredoxin-interacting protein, hematopoietic stem cells, and hematopoiesis.
Jung H; Choi I
Curr Opin Hematol; 2014 Jul; 21(4):265-70. PubMed ID: 24686462
[TBL] [Abstract][Full Text] [Related]
30. ROS/TXNIP pathway contributes to thrombin induced NLRP3 inflammasome activation and cell apoptosis in microglia.
Ye X; Zuo D; Yu L; Zhang L; Tang J; Cui C; Bao L; Zan K; Zhang Z; Yang X; Chen H; Tang H; Zu J; Shi H; Cui G
Biochem Biophys Res Commun; 2017 Apr; 485(2):499-505. PubMed ID: 28202418
[TBL] [Abstract][Full Text] [Related]
31. Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice.
Park AM; Suzuki YJ
J Appl Physiol (1985); 2007 May; 102(5):1806-14. PubMed ID: 17272404
[TBL] [Abstract][Full Text] [Related]
32. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
33. The desumoylating enzyme sentrin-specific protease 3 contributes to myocardial ischemia reperfusion injury.
Gao L; Zhao Y; He J; Yan Y; Xu L; Lin N; Ji Q; Tong R; Fu Y; Gao Y; Su Y; Yuan A; He B; Pu J
J Genet Genomics; 2018 Mar; 45(3):125-135. PubMed ID: 29576508
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin-Interacting Protein Mediates NLRP3 Inflammasome Activation Involved in the Susceptibility to Ischemic Acute Kidney Injury in Diabetes.
Xiao YD; Huang YY; Wang HX; Wu Y; Leng Y; Liu M; Sun Q; Xia ZY
Oxid Med Cell Longev; 2016; 2016():2386068. PubMed ID: 27867451
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.
Yoshioka J; Imahashi K; Gabel SA; Chutkow WA; Burds AA; Gannon J; Schulze PC; MacGillivray C; London RE; Murphy E; Lee RT
Circ Res; 2007 Dec; 101(12):1328-38. PubMed ID: 17916779
[TBL] [Abstract][Full Text] [Related]
36. Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice.
Mastrocola R; Collino M; Penna C; Nigro D; Chiazza F; Fracasso V; Tullio F; Alloatti G; Pagliaro P; Aragno M
Oxid Med Cell Longev; 2016; 2016():3480637. PubMed ID: 26788246
[TBL] [Abstract][Full Text] [Related]
37. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.
Kawaguchi M; Takahashi M; Hata T; Kashima Y; Usui F; Morimoto H; Izawa A; Takahashi Y; Masumoto J; Koyama J; Hongo M; Noda T; Nakayama J; Sagara J; Taniguchi S; Ikeda U
Circulation; 2011 Feb; 123(6):594-604. PubMed ID: 21282498
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
[TBL] [Abstract][Full Text] [Related]
39. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
40. C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation.
Miyazaki Y; Kaikita K; Endo M; Horio E; Miura M; Tsujita K; Hokimoto S; Yamamuro M; Iwawaki T; Gotoh T; Ogawa H; Oike Y
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1124-32. PubMed ID: 21330607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
